CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 164 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03347656
NCT03347656N/ACompleted

Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients

Beth Israel Deaconess Medical Center·observational·Posted Nov 20, 2017·Updated Aug 20, 2024

In Brief

An observational study for Sarcopenia and 3 related conditions. Completed, enrolled 164 participants across 3 sites in 2 countries.

Detailed Summary

The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) predicts discharge disposition, 90 day Barthel Index and other outcomes like muscle wasting (expressed as decrease in rectus femoris cross sectional area (RF-CSA) in the paretic and non-paretic limb measured by bedside ultrasound), and ICU length of stay (LOS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, United States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 20, 2017
Enrollment StartOct 12, 2017
Primary CompletionDec 20, 2019
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.6 years ago